Us Physicalrapy Stock Revenue
| USPH Stock | USD 105.45 0.49 0.47% |
US Physicalrapy fundamentals help investors to digest information that contributes to US Physicalrapy's financial success or failures. It also enables traders to predict the movement of USPH Stock. The fundamental analysis module provides a way to measure US Physicalrapy's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to US Physicalrapy stock.
| Last Reported | Projected for Next Year | ||
| Total Revenue | 604.8 M | 635 M |
USPH | Revenue |
US Physicalrapy Company Revenue Analysis
US Physicalrapy's Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Current US Physicalrapy Revenue | 604.8 M |
Most of US Physicalrapy's fundamental indicators, such as Revenue, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, US Physicalrapy is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Historical and Projected quarterly revenue of USPH
Projected quarterly revenue analysis of US Physicalrapy provides investors and stakeholders with an insight into the company's performance and growth prospects. When actual revenues of US Physicalrapy match or exceed analyst estimates, it positively influences investor confidence and market perception, often leading to a rise in US Physicalrapy's stock price.
USPH Revenue Driver Correlations
Understanding the fundamental principles of building solid financial models for US Physicalrapy is extremely important. It helps to project a fair market value of USPH Stock properly, considering its historical fundamentals such as Revenue. Since US Physicalrapy's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of US Physicalrapy's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of US Physicalrapy's interrelated accounts and indicators.
| 0.25 | 0.22 | 0.63 | 0.32 | 0.7 | ||
| 0.25 | 1.0 | 0.65 | 0.99 | 0.56 | ||
| 0.22 | 1.0 | 0.62 | 0.98 | 0.52 | ||
| 0.63 | 0.65 | 0.62 | 0.72 | 0.99 | ||
| 0.32 | 0.99 | 0.98 | 0.72 | 0.64 | ||
| 0.7 | 0.56 | 0.52 | 0.99 | 0.64 |
Click cells to compare fundamentals
USPH Revenue Historical Pattern
Today, most investors in US Physicalrapy Stock are looking for potential investment opportunities by analyzing not only static indicators but also various US Physicalrapy's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's revenue growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of US Physicalrapy revenue as a starting point in their analysis.
US Physicalrapy Revenue |
| Timeline |
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
| Competition |
USPH Current Deferred Revenue
Current Deferred Revenue |
|
Based on the latest financial disclosure, US Physicalrapy reported 604.8 M of revenue. This is 92.07% lower than that of the Health Care Providers & Services sector and significantly higher than that of the Health Care industry. The revenue for all United States stocks is 93.59% higher than that of the company.
USPH Revenue Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses US Physicalrapy's direct or indirect competition against its Revenue to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of US Physicalrapy could also be used in its relative valuation, which is a method of valuing US Physicalrapy by comparing valuation metrics of similar companies.US Physicalrapy is currently under evaluation in revenue category among related companies.
US Physicalrapy ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, US Physicalrapy's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to US Physicalrapy's managers, analysts, and investors.Environmental | Governance | Social |
US Physicalrapy Institutional Holders
Institutional Holdings refers to the ownership stake in US Physicalrapy that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of US Physicalrapy's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing US Physicalrapy's value.| Shares | Riverbridge Partners Llc | 2024-03-31 | 376.7 K | Gw&k Investment Management, Llc | 2023-12-31 | 345.7 K | Geode Capital Management, Llc | 2023-12-31 | 314.4 K | Northern Trust Corp | 2023-12-31 | 228.6 K | Ensign Peak Advisors Inc | 2023-12-31 | 215 K | Fmr Inc | 2023-12-31 | 199.3 K | Fred Alger Management, Llc | 2023-12-31 | 191.5 K | Envestnet Asset Management Inc | 2023-12-31 | 177.3 K | Ameriprise Financial Inc | 2023-12-31 | 168.6 K | Blackrock Inc | 2023-12-31 | 2.3 M | Kayne Anderson Rudnick Investment Management Llc | 2023-12-31 | 1.4 M |
USPH Fundamentals
| Return On Equity | 0.0647 | ||||
| Return On Asset | 0.0443 | ||||
| Profit Margin | 0.05 % | ||||
| Operating Margin | 0.09 % | ||||
| Current Valuation | 1.87 B | ||||
| Shares Outstanding | 15.07 M | ||||
| Shares Owned By Insiders | 1.60 % | ||||
| Shares Owned By Institutions | 98.40 % | ||||
| Number Of Shares Shorted | 706.97 K | ||||
| Price To Earning | 34.35 X | ||||
| Price To Book | 3.25 X | ||||
| Price To Sales | 2.59 X | ||||
| Revenue | 604.8 M | ||||
| Gross Profit | 112.02 M | ||||
| EBITDA | 85.25 M | ||||
| Net Income | 18.14 M | ||||
| Cash And Equivalents | 48.57 M | ||||
| Cash Per Share | 3.73 X | ||||
| Total Debt | 258.59 M | ||||
| Debt To Equity | 0.57 % | ||||
| Current Ratio | 1.43 X | ||||
| Book Value Per Share | 31.84 X | ||||
| Cash Flow From Operations | 82.81 M | ||||
| Short Ratio | 9.58 X | ||||
| Earnings Per Share | 1.13 X | ||||
| Price To Earnings To Growth | 6.94 X | ||||
| Target Price | 121.38 | ||||
| Number Of Employees | 3.9 K | ||||
| Beta | 1.39 | ||||
| Market Capitalization | 1.6 B | ||||
| Total Asset | 1.03 B | ||||
| Retained Earnings | 223.77 M | ||||
| Working Capital | 131.19 M | ||||
| Current Asset | 60.18 M | ||||
| Current Liabilities | 19.01 M | ||||
| Annual Yield | 0.02 % | ||||
| Five Year Return | 1.01 % | ||||
| Net Asset | 1.03 B | ||||
| Last Dividend Paid | 1.73 |
About US Physicalrapy Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze US Physicalrapy's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of US Physicalrapy using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of US Physicalrapy based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
When determining whether US Physicalrapy offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of US Physicalrapy's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Us Physicalrapy Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Us Physicalrapy Stock:Check out US Physicalrapy Piotroski F Score and US Physicalrapy Altman Z Score analysis. For more detail on how to invest in USPH Stock please use our How to Invest in US Physicalrapy guide.You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Complementary Tools for USPH Stock analysis
When running US Physicalrapy's price analysis, check to measure US Physicalrapy's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy US Physicalrapy is operating at the current time. Most of US Physicalrapy's value examination focuses on studying past and present price action to predict the probability of US Physicalrapy's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move US Physicalrapy's price. Additionally, you may evaluate how the addition of US Physicalrapy to your portfolios can decrease your overall portfolio volatility.
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges |
Is US Physicalrapy's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of US Physicalrapy. If investors know USPH will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about US Physicalrapy listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.19) | Dividend Share 1.73 | Earnings Share 1.13 | Revenue Per Share 41.242 | Quarterly Revenue Growth 0.048 |
The market value of US Physicalrapy is measured differently than its book value, which is the value of USPH that is recorded on the company's balance sheet. Investors also form their own opinion of US Physicalrapy's value that differs from its market value or its book value, called intrinsic value, which is US Physicalrapy's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because US Physicalrapy's market value can be influenced by many factors that don't directly affect US Physicalrapy's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between US Physicalrapy's value and its price as these two are different measures arrived at by different means. Investors typically determine if US Physicalrapy is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, US Physicalrapy's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.